Keywords: strong, ph, iii, data, cephalon, fentora, drugmaker

Strong Ph III data for Cephalon's Fentora

Article | 20 August 2007

Print This

US drugmaker Cephalon has reported positive results from a 12-week, Phase III trial of Fentora (fentanyl buccal tablet) in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in